Key Takeaways
- Probiotic tea benefits are real but strain-dependent. Teas using heat-stable spore-forming bacteria (primarily Bacillus coagulans, also known as BC30) are backed by clinical trial evidence. Teas using standard Lactobacillus or Bifidobacterium strains are not — those bacteria die at brewing temperatures.
- Gut health is the best-supported benefit. Multiple systematic reviews and randomized controlled trials have confirmed that Bacillus coagulans supplementation improves digestive comfort and IBS symptoms, with results typically emerging after 4–8 weeks of consistent use.
- The heat survival question is settled for spore-forming strains. In vitro evidence confirms that Bacillus coagulans-related strains survive standard brewing temperatures — their spore form is heat-resistant, and spores germinate into active bacteria in the GI tract.
- Naturally fermented teas (kombucha, pu-erh) sidestep the heat issue entirely — the live cultures are embedded in the fermented beverage matrix. Kombucha human trials now show modest gut microbiome modulation, though results vary significantly between products.
- Safety is generally favorable for healthy adults. A meta-analysis of multiple RCTs found probiotic side effects not significantly different from placebo. Specific cautions apply for immunocompromised individuals, those on warfarin, and pregnant or nursing individuals.
- Japan has a distinct probiotic tea tradition. Post-fermented teas like awa bancha (阿波番茶) and ishizuchi kurocha (石鎚黒茶) are naturally fermented using endemic lactic acid bacteria strains — a tradition that Japanese researchers are now characterizing scientifically, yielding insights absent from international literature.
You've seen probiotic teas on every wellness shelf. The labels promise better digestion, stronger immunity, and a happier gut — all from a cup of tea. But a reasonable question nags: if hot water kills bacteria, how is any probiotic actually surviving the brewing process? And if the bacteria don't survive, what are you actually drinking?
These aren't trivial questions. The answer depends on something most probiotic tea labels don't explain clearly: which type of probiotic tea you're looking at, and which bacterial strain it uses. Not all probiotic teas work the same way. Some rely on heat-stable spore-forming bacteria specifically engineered to survive boiling water. Others are naturally fermented beverages where probiotics are embedded in the liquid itself. And some commercial teas use strains that simply cannot survive the cup at all.
We've reviewed the available clinical evidence — including research from Japanese academic databases that most English-language guides don't reference — to give you a clear picture of what probiotic tea can and can't do, which formats are backed by science, and what realistic expectations look like.
What Is Probiotic Tea? Types & How They Differ
The phrase "probiotic tea" is used for two very different products. Understanding which type you're dealing with changes everything — from whether the probiotics are alive when you drink them, to what health benefits the evidence actually supports.
Natural Probiotic Teas (Fermented)
These teas get their probiotic content through fermentation — live bacteria are produced during the brewing process, so no heat-killing issue arises.
Kombucha is the most widely recognized example. It's made by fermenting sweetened tea with a SCOBY (symbiotic culture of bacteria and yeast), a rubbery culture that produces acetic acid, B vitamins, organic acids, and live bacteria. A systematic review published in the Annals of Epidemiology identified kombucha as a beverage with meaningful health claim potential, though the authors noted that most evidence had been preclinical at the time of that review. [8] Human clinical trials have since emerged, showing modest gut microbiome modulation.
Pu-erh tea is a post-fermented tea from China — and to a lesser extent from Japan — that undergoes a secondary microbial fermentation after drying. Its microbial community includes bacteria, yeasts, and molds, giving it a distinct earthy flavor and a probiotic-adjacent profile. Pu-erh is less studied in clinical trials than kombucha but is receiving growing research interest.
Japanese post-fermented teas (awa bancha, goishi-cha, ishizuchi kurocha) represent a third distinct category. These are traditionally fermented using naturally occurring lactic acid bacteria through anaerobic fermentation — a process documented in Japanese research databases but largely absent from international health literature. We'll cover these in detail in the Japanese Research section.
Supplemental Probiotic Teas (Added Bacteria)
These are conventional tea bags or ready-to-drink teas with specific probiotic strains added during production. This is the format sold by major brands like Twinings and Celestial Seasonings — a regular green or black tea with a probiotic added.
The challenge here is obvious: standard probiotic strains (Lactobacillus, Bifidobacterium) are killed at temperatures above 40–60°C. Black tea is brewed at 90–95°C. So how do any probiotics survive?
They don't — unless the manufacturer uses heat-stable, spore-forming strains. The dominant strain used in commercial probiotic teas is Bacillus coagulans GBI-30, 6086 (sold under the trade name GanedenBC30, now Howaru BC30). Unlike fragile vegetative bacteria, BC30 exists in a dormant spore form that withstands temperatures up to 100°C. When the spore reaches the warm, moist environment of the gastrointestinal tract, it germinates into an active probiotic bacterium.
When reading a label: If it says Bacillus coagulans or lists the strain code GBI-30, 6086 — the probiotics are heat-stable. If it says Lactobacillus acidophilus, Bifidobacterium lactis, or any non-spore-forming strain — those bacteria will not survive in a hot tea.
Knowing this distinction puts you in a better position to evaluate any probiotic tea you're considering. The rest of the evidence discussion hinges on it.
The Heat Problem: Can Probiotics Survive Hot Water?
This is the most searched question about probiotic tea — and rightly so. Let's be clear about what the evidence actually shows.
Why Most Probiotics Can't Survive Tea
Standard probiotic strains denature above 40–60°C. The proteins in their cell membranes unfold and lose function at these temperatures, killing the bacteria before you take a sip. Given that green tea is brewed at 70–80°C and black tea at 90–95°C, even the lower end of typical brewing temperatures destroys standard Lactobacillus and Bifidobacterium strains.
This isn't a criticism of those strains — they're effective in cold formats like yogurt, kefir, capsules, and chilled beverages. They simply weren't designed for hot liquid delivery.
How Spore-Forming Bacteria Solve the Problem
Spore-forming bacteria like Bacillus coagulans take a different biological strategy. Instead of existing as vulnerable vegetative cells, BC30 forms dormant endospores — protective structures that shield the bacteria from heat, pressure, and desiccation. These spores remain viable at temperatures up to 100°C.
Once the spore passes through the stomach acid and reaches the warmer, more hospitable environment of the small intestine, it germinates back into an active bacterium. This two-stage mechanism is why BC30 was specifically selected for use in hot beverage applications.
In vitro brewing confirmation: A study published in PMC tested nine strains of Heyndrickxia coagulans (the taxonomic reclassification of many Bacillus coagulans strains) in a pu-erh tea brewing simulation. Probiotic viability was confirmed after standard brewing conditions. [13] A separate study examining ready-to-drink probiotic tea formulations found viable counts of over 10 log CFU/mL were achievable in green tea beverages when prebiotic support was included. [14]
It's worth noting: this heat-survival evidence is in vitro. No human randomized controlled trial has yet compared BC30 delivered specifically in brewed tea format versus capsule. The clinical evidence for BC30's gut benefits comes from capsule and supplement trials — and the heat-stability data supports the reasonable inference that BC30 in tea delivers live bacteria, but this hasn't been confirmed in a human tea-specific trial.
What This Means Practically
| Strain Type | Survives Brewing? | Clinical Evidence Base |
|---|---|---|
| Bacillus coagulans (BC30, spore-forming) | Yes — up to 100°C | Strong — multiple RCTs and meta-analyses |
| Bacillus subtilis (DE111, spore-forming) | Yes | Moderate |
| Lactobacillus / Bifidobacterium (vegetative) | No — dies above 60°C | N/A in tea format |
| Kombucha / fermented teas (live cultures in liquid) | N/A — no heat involved | Emerging-Moderate |
The practical takeaway: check the strain on the label before assuming a probiotic tea will deliver live bacteria. Fermented teas (kombucha, pu-erh) bypass this issue entirely — but their bacterial counts are variable, and the evidence base differs from that of BC30-based commercial teas.
Probiotic Tea Benefits: What the Evidence Shows
The evidence for probiotic tea benefits is not uniform across health areas. Gut health has the most rigorous backing; other areas are supported by weaker or more indirect evidence. Here's an honest breakdown, organized by evidence strength.
Gut Health & Digestive Comfort: Strong Evidence (BC30) / Moderate Evidence (Kombucha)
This is the best-supported benefit area, and the clinical trial evidence is substantial — though important caveats about delivery format apply.
For BC30 / Bacillus coagulans:
A systematic review and meta-analysis published in Gastroenterology & Hepatology concluded that Bacillus coagulans is a potent intervention for IBS symptoms, with multiple RCTs supporting significant improvements in GI comfort. [1] A network meta-analysis published in Frontiers in Cellular and Infection Microbiology analyzed probiotic strains for IBS treatment across multiple trials and found B. coagulans showed prominent efficacy within the network. [2] A strain-specific analysis in Nutrients further confirmed outcome-specific efficacy for specific BC strains including MTCC 5856. [3]
At the mechanistic level, a randomized, double-blind, placebo-controlled trial published in Medicine followed healthy adults taking Bacillus coagulans MTCC 5856 and found it significantly modulated gut microbiota composition. [4] Timelines: most BC30 trials show measurable changes in bowel function within 4 weeks, with full gut microbiome shifts apparent at 8 weeks.
Important caveat: all of this BC30 clinical evidence used capsule or supplement delivery — not brewed tea. The inference that BC30 in tea provides similar benefits is supported by the heat-stability evidence, but it hasn't been confirmed in a human trial using tea as the delivery vehicle. This gap is important to acknowledge.
For kombucha:
A controlled human study published in Scientific Reports found that kombucha consumption modulated the gut microbiome and health markers in participants. [5] An RCT in Current Developments in Nutrition found that kombucha enriched with inulin and vitamins improved bowel emptying in females with constipation-predominant IBS. [6]
A systematic review of kombucha clinical trials published in Fermentation in a more recent year evaluated available human trials. It found modest gut microbiota modulation effects but flagged significant heterogeneity across studies — different producers, fermentation sources, and bacterial populations make it difficult to generalize results from one kombucha product to another. [7]
Immune System Support: Moderate Evidence
The connection between gut health and immune function is well-established in the scientific literature. Approximately 70% of immune cells reside in the gut-associated lymphoid tissue (GALT), meaning changes to gut microbiome composition can have measurable downstream effects on immune activity.
Probiotic tea's specific role in immunity is less directly proven, but some relevant evidence exists. Tea polyphenol-probiotic interactions have been shown to modulate gut microbiota in ways that facilitate immune homeostasis. [16] A randomized controlled trial published in Nutrients found that green tea kombucha consumption in individuals with excess body weight led to changes in inflammation markers, suggesting some immune-modulating effect. [11]
Be cautious with "boosts immunity" language from probiotic tea marketing. The honest positioning is: probiotic tea may support a healthy immune environment through gut microbiome modulation — but tea-specific immune trials are limited, and most of the immunity-probiotics research is from supplement studies, not tea studies.
Metabolic Health: Emerging Evidence
The most compelling metabolic finding to date is a pilot RCT published in Frontiers in Nutrition that compared kombucha tea to diet soda in adults with type 2 diabetes. Participants drinking kombucha showed reduced fasting blood glucose levels compared to the control group. [9] This was a crossover design, with n=12 per group — well-designed but small. Replication in larger trials is needed before treating this as a reliable metabolic health benefit.
Animal models have also shown gut microbiota and intestinal health improvements in rats on high-fat diets given kombucha. [10] These findings are directionally encouraging, but animal results do not translate automatically to human benefit.
Honest positioning: metabolic health is emerging territory for probiotic tea. The pilot RCT is interesting, but one small study is not sufficient evidence to claim metabolic benefits for everyday probiotic tea drinking.
Mental Health / Gut-Brain Axis: Preliminary Evidence
The gut-brain axis is an active and well-funded area of research — roughly 90% of serotonin, the neurotransmitter often linked to mood, is produced in the gut. It's a plausible pathway for probiotics to influence mood and stress. However, the current human clinical trial evidence connecting probiotic tea specifically to mental health outcomes is very thin. Most gut-brain research uses dedicated probiotic supplements with specific strains, not teas. Position this as intriguing science to watch — not a proven tea benefit.
Tea as a Prebiotic: The Polyphenol Connection
One of the most underappreciated aspects of probiotic tea is what the tea base does — not just the added bacteria.
Green, black, white, and oolong teas are naturally rich in polyphenols — specifically EGCG (epigallocatechin gallate), theaflavins, and thearubigins. These compounds are not absorbed in the upper GI tract; instead, they travel to the colon where they act as substrates (food sources) for beneficial gut bacteria. In scientific terms, this makes tea a prebiotic.
What does this mean in practice? A human trial found that drinking approximately 1,000 mL of green tea daily for 10 days produced prebiotic effects — specifically, a significant increase in fecal Bifidobacterium counts and improvements in the colonic environment. [12] Separately, research has confirmed that tea polyphenols, particularly EGCG, selectively inhibit pathogenic bacteria while creating a more favorable environment for Bifidobacterium and Lactobacillus populations.
The synbiotic effect: when a tea contains both added probiotic bacteria (the probiotic) and tea polyphenols (the prebiotic food for those bacteria), the combination creates a synbiotic beverage — one that may enhance bacterial survival and activity beyond either component alone. Research on green tea as a co-ingredient in probiotic formulations found that adding 5–15% green tea extract increased Lactobacillus acidophilus viability and dramatically enhanced antioxidative properties. [15]
This synbiotic angle is unique to probiotic tea as a format — a capsule doesn't deliver the polyphenol prebiotic environment that tea naturally provides. It's a genuine differentiator for BC30-in-tea products compared to equivalent BC30 capsules.
Probiotic Tea vs. Supplements vs. Fermented Foods
If you're evaluating whether probiotic tea is "worth it" compared to a dedicated probiotic supplement or fermented foods like yogurt and kefir, this comparison helps clarify the trade-offs.
| Format | CFU Count per Serving | Strain Control | Survives Heat | Evidence Base | Synbiotic Benefit |
|---|---|---|---|---|---|
| Probiotic tea (BC30) | 500M–1B CFU | Specific (BC30) | Yes | Moderate (BC30 trials, capsule delivery) | Yes — tea polyphenols as prebiotics |
| Probiotic supplement (capsule) | 1B–50B+ CFU | Specific | N/A | Strong (broad clinical trial base) | No (unless formula includes prebiotics) |
| Kombucha | Variable: 1M–10B+ CFU/bottle | Mixed strains, variable | N/A (cold-fermented) | Emerging | Partial (tea polyphenols present) |
| Yogurt / kefir | Variable: 10B+ CFU/serving | Mixed strains | N/A (cold) | Moderate | No |
| Pu-erh tea | Low, variable | Mixed microbial community | N/A (post-fermented) | Emerging | Yes — tea polyphenols present |
Key takeaway from this table: Probiotic supplements still deliver higher and more consistent CFU counts than any tea format. For someone managing a diagnosed gut condition who needs therapeutic doses, dedicated supplements with specific, clinically studied strains are the more reliable option.
Where probiotic tea holds its own: convenience, palatability, daily ritual integration, and the synbiotic polyphenol benefit. For healthy adults looking to support their gut microbiome as a daily habit — rather than address a clinical condition — BC30 probiotic tea is a reasonable, evidence-informed choice.
Safety Considerations
Probiotic tea is generally well-tolerated by healthy adults, but there are specific populations and interactions that warrant attention.
Overall Safety Profile
A meta-analysis published in Nutrients examined probiotic-related side effects across multiple RCTs in adults with inflammatory bowel disease and found that probiotic-related adverse events were not significantly different from placebo (risk ratio approximately 1.0). [17] A pharmacovigilance analysis of the FDA's Adverse Event Reporting System covering more than 18 years found that the majority of reported probiotic adverse events were mild GI symptoms. [18]
BC30 itself carries a GRAS (Generally Recognized As Safe) designation from the US Food and Drug Administration. It has been used in commercial food and beverage products for years without significant safety concerns.
Common Side Effects
An adjustment period of 1–2 weeks is normal when starting any probiotic. During this period, some people experience mild and temporary:
- Bloating or increased gas
- Loose stools or minor changes in bowel frequency
- Occasional mild stomach discomfort
These typically resolve as the gut microbiome adjusts. They are not a reason to stop unless they persist beyond two weeks or are severe.
Kombucha-specific considerations: Home-brewed kombucha carries a contamination risk if preparation is improper — commercial pasteurized products are safer for sensitive individuals. Kombucha contains trace alcohol (typically 0.5–3%) and is acidic, which can irritate the esophagus in those with acid reflux. It also contains caffeine from the tea base.
Drug Interactions
These interactions are not specific to probiotic tea but apply to probiotics broadly:
- Warfarin (blood thinner): Kombucha contains trace alcohol and is acidic — consult your prescriber before adding it to your routine
- Immunosuppressants (cyclosporine, tacrolimus): Probiotic-induced immune modulation could theoretically affect immunosuppressant efficacy
- Antifungal medications: Kombucha contains Saccharomyces yeasts that may be affected by antifungal treatment
- Antibiotics: Avoid taking probiotic products during an antibiotic course, as antibiotics will kill the probiotic bacteria; resume two or more hours apart from antibiotic doses, or after the course ends
Note that these drug interactions are based on general probiotic biology and pharmacological reasoning, not on tea-specific clinical trials. Consult your healthcare provider if you take any of the above medications.
Who Should Use Caution or Avoid
| Population | Guidance |
|---|---|
| Immunocompromised individuals (organ transplant, HIV/AIDS, cancer chemotherapy) | Avoid without physician clearance — theoretical infection risk from live organisms |
| Critically ill patients | Clinical literature contains rare case reports of bacteremia from probiotic organisms in ICU settings |
| Pregnant or nursing individuals | Evidence is limited; consult healthcare provider before starting any probiotic product |
| Infants under 6 months / premature neonates | Safety not established; clinical trials exclude these populations |
| Individuals with severe gut barrier dysfunction | Consult a gastroenterologist |
Realistic Expectations
Probiotic tea is not a treatment for any diagnosed medical condition. It will not cure IBS, IBD, or any other gut disorder. It will not eliminate infections. Benefits — where they occur — are supportive, cumulative, and most observable after 4–8 weeks of consistent daily consumption.
For higher-dose therapeutic uses, or when managing an active digestive health condition, a dedicated probiotic supplement with a clinically validated strain at a proven dose is a more reliable approach than tea-format delivery.
Probiotic Tea in Japanese Research & Tradition
Most discussions of probiotic tea focus on Bacillus coagulans teas and kombucha. Japan offers a distinct third path — one that predates the modern probiotic supplement industry by centuries and is only now being characterized scientifically.
Japan's Post-Fermented Tea Tradition
Japan's most compelling probiotic tea tradition involves regional post-fermented teas that use naturally occurring lactic acid bacteria (LAB) — not added laboratory strains, not SCOBY cultures, but bacteria that develop through traditional anaerobic fermentation unique to each region.
Awa bancha (阿波番茶), produced exclusively in Tokushima Prefecture on Shikoku Island, undergoes a purely anaerobic lactic acid fermentation — unlike most post-fermented teas that use a two-stage process. Japanese research published in J-STAGE (the platform for Japanese academic journals) has characterized the dominant LAB strains as Lactobacillus pentosus and L. plantarum, and has examined their effects on gut microbiota composition in animal models. [20] A separate microbial characterization study documented the LAB profile of awa bancha in detail. [21]
Why this matters: Awa bancha's LAB strains are endemic — they arise from the local environment, the tea leaf, and the fermentation vessel. These are place-specific microorganisms that cannot be replicated in a commercial supplement format. The resulting beverage contains GABA, D-amino acids, and tea polyphenols alongside the live bacteria — a whole-food probiotic matrix rather than a single isolated strain.
Ishizuchi Kurocha and Goishi-cha: Two-Stage Fermentation
Ishizuchi kurocha (石鎚黒茶) and goishi-cha (碁石茶) are two-stage post-fermented teas from Ehime and Kochi prefectures respectively. They undergo an initial aerobic mold fermentation followed by anaerobic lactic acid bacteria fermentation — producing a microbial diversity that is unique in the global tea landscape.
Japanese prefectural research institutes have documented notable properties in these teas: GABA content in ishizuchi kurocha was found to be approximately six times higher than standard black tea, and anti-allergic properties (specifically pollen allergy symptom reduction and mast cell inhibition) have been investigated in laboratory studies. Microbial characterization studies have been published in Japanese academic journals for both goishi-cha [22] and ishizuchi kurocha. [23]
An important distinction for readers: these Japanese post-fermented teas are traditional foods characterized by excellent scientific documentation of their microbial profiles. They are not clinically validated therapeutic products in the way that BC30 supplements are. Human clinical trial evidence for health outcomes from drinking awa bancha or ishizuchi kurocha is still limited — what exists is microbiological research and animal models. The tradition and the science are both real, but the evidence hierarchy is different.
The Broader Japanese Probiotic Research Context
Japan has a foundational relationship with probiotic research that often goes unrecognized internationally. Mitsuo Mitsuoka (光岡知足), a Japanese researcher, helped pioneer gut microbiome science from its origins tracing back to Metchnikoff's theories, building one of the world's earliest programs studying human intestinal bacteria. His work, reviewed in a J-STAGE publication, traces the evolution of Japanese probiotic research from fermented milk traditions through to modern functional food applications. [24]
Yakult's Lactobacillus casei Shirota strain — perhaps Japan's most famous probiotic export — originated from this tradition. Japanese research has continued expanding its study: a J-STAGE publication on the Shirota strain has examined its effects on stress reduction and sleep quality, demonstrating that Japanese probiotic research extends well beyond gut function into the gut-brain axis. [25]
The practical implication for readers: Japan's probiotic tradition offers a scientifically serious, whole-food perspective on probiotic tea that differs from both the international supplement model (isolated single-strain, high-CFU capsules) and the kombucha model (SCOBY-based mixed fermentation). It's worth knowing about — both for its scientific legitimacy and as a reminder that probiotic tea is not a modern wellness invention.
Our Recommendations
For readers who find the evidence compelling and want to integrate probiotic gut support into their daily routine, a dedicated Japanese probiotic supplement offers a higher-dose, clinically validated approach that complements — or, for therapeutic purposes, may outperform — tea-format delivery.
Yakult Probiotic Dual-Strain Gut Health Supplement
Why We Selected This: Yakult Honsha Co., Ltd. is one of Japan's most science-backed probiotic producers, with decades of proprietary research on Lactobacillus strains for gut health and immunity. Their probiotic supplement combines two clinically relevant strains — Bifidobacterium and Lactobacillus — in a concentrated format that delivers consistent CFU counts without the heat-stability constraints of a tea bag.
For readers who drink probiotic tea as a daily ritual but want the additional assurance of a higher-dose probiotic from one of Japan's most respected producers, this supplement pairs well with a probiotic tea routine, addressing the CFU count gap that tea formats inherently have. It is also the appropriate format for those looking for gut health support backed by a longstanding Japanese research tradition.
View Yakult Probiotic Dual-Strain Gut Health Supplement →
For readers interested in exploring how Japanese probiotic supplementation differs from international approaches in more depth, our guide to Japanese probiotic supplements covers the clinical evidence and what sets Japanese formulations apart.
Conclusion
Probiotic tea occupies an honest middle ground in the supplement landscape. It is not magic, and it is not marketing fiction. The clinical evidence tells a nuanced story: BC30-based probiotic teas deliver heat-stable bacteria supported by rigorous clinical trial evidence for gut health — even if the specific trials used capsule delivery rather than tea format. Kombucha has real human trial data showing modest gut microbiome modulation, though results vary by product. And the polyphenols in tea itself are a genuine prebiotic that makes the format uniquely synbiotic.
The key calibrations for anyone evaluating probiotic tea: check for a spore-forming strain on the label, manage expectations around CFU counts compared to supplements, and commit to at least 4–8 weeks of consistent daily use before assessing results. For those with diagnosed gut conditions or who want therapeutic-grade probiotic doses, a dedicated supplement remains the more reliable choice.
If you'd like to explore dedicated Japanese probiotic supplements — particularly formulations from producers with longstanding research programs — our curated Japanese probiotic supplement guide covers what the clinical research shows about supplement formats from Japan's leading producers.
This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any supplement regimen, especially if you have existing health conditions or take medications. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
Frequently Asked Questions
- Bacillus coagulans as a potent intervention for treating irritable bowel syndrome: a systematic review and meta-analysis of randomized control trials
- Efficacy of probiotics for irritable bowel syndrome: a systematic review and network meta-analysis
- Outcome-specific efficacy of different probiotic strains in irritable bowel syndrome
- Probiotic modulation of gut microbiota by Bacillus coagulans MTCC 5856 in healthy subjects: a randomized, double-blind, placebo-control study
- Modulating the human gut microbiome and health markers through kombucha consumption: a controlled clinical study
- Kombucha-based drink enriched with inulin and vitamins for the management of constipation-predominant IBS
- Benefits of kombucha consumption: a systematic review of clinical trials focused on microbiota and metabolic health
- Kombucha: a systematic review of the empirical evidence of human health benefit
- Kombucha tea as an anti-hyperglycemic agent in humans with diabetes: a randomized controlled pilot investigation
- Gut microbiota and intestinal health effects of green and black tea kombuchas in rats on a high-fat/high-fructose diet
- Green tea kombucha impacts inflammation and salivary microbiota: a randomized controlled trial
- Green tea prebiotic effects on gut microbiota — human trial data
- Heyndrickxia coagulans survival in pu-erh tea brewing — in vitro assessment
- Probiotic viable counts in ready-to-drink tea beverages
- Green tea improves Lactobacillus viability and antioxidative properties in fermented products
- Tea polyphenols and immune homeostasis via gut microbiota modulation
- Side effects associated with probiotic use in adult patients with inflammatory bowel disease
- A pharmacovigilance study on probiotic preparations based on the FDA Adverse Event Reporting System 2005–2023
- Safety of probiotics in humans: a dark side revealed?
